Editorial
An old acquaintance with new trends: Systemic lupus erythematosus
Un viejo conocido con nuevas tendencias: lupus eritematoso sistémico
a Reumavance Group, Rheumatology Section, Department of Internal Medicine, Fundación Santa Fe de Bogotá University Hospital, Bogota, Colombia
b Department of Internal Medicine, School of Medicine, Universidad de Los Andes, Bogota, Colombia
c Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia
d Cell Immunology and Immunogenetics Group (GICIG), School of Medicine, Universidad de Antioquia, Medellin, Colombia
e Rheumatology Group, School of Medicine, Universidad de Antioquia, Medellín, Colombia
f Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain
Read
499
Timeswas read the article
133
Total PDF
366
Total HTML
Share statistics
array:22 [ "pii" => "S0121812321000657" "issn" => "01218123" "doi" => "10.1016/j.rcreu.2021.05.001" "estado" => "S300" "fechaPublicacion" => "2021-06-01" "aid" => "1893" "copyright" => "Asociación Colombiana de Reumatología" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Colomb Reumatol. 2021;28 Supl 1:1-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S0121812321000426" "issn" => "01218123" "doi" => "10.1016/j.rcreu.2021.02.005" "estado" => "S300" "fechaPublicacion" => "2021-06-01" "aid" => "1878" "copyright" => "Asociación Colombiana de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Rev Colomb Reumatol. 2021;28 Supl 1:3-11" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review Article</span>" "titulo" => "Osteoporosis and osteonecrosis in systemic lupus erythematosus" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "3" "paginaFinal" => "11" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Osteoporosis y osteonecrosis en el lupus eritematoso sistémico" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 560 "Ancho" => 1255 "Tamanyo" => 92907 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Bilateral avascular necrosis of the femoral heads in a patient with systemic lupus erythematosus. Panel A shows a pelvic posterior-anterior radiography where subchondral sclerosis is evident at the femoral heads, bilaterally (white arrows). No insufficiency fractures are seen and articular space is preserved in both joints. This X-ray would correspond to a grade 2 according to Arlet and Ficat's classification. Panel B shows a pelvic magnetic resonance imaging T1 coronal cut with crescentic areas of T1 hypointensity (white arrows) consistent with avascular necrosis involving two thirds of the articular surface bilaterally. There are no insufficiency fractures. This second technique shows a grade 3 AVN as per Arlet and Ficat.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Andreu Fernández-Codina, Janet E. Pope" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Andreu" "apellidos" => "Fernández-Codina" ] 1 => array:2 [ "nombre" => "Janet E." "apellidos" => "Pope" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0121812321000426?idApp=UINPBA00004N" "url" => "/01218123/00000028000000S1/v4_202404250855/S0121812321000426/v4_202404250855/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "An old acquaintance with new trends: Systemic lupus erythematosus" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1" "paginaFinal" => "2" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Gerardo Quintana-Lopez, Gloria Vásquez, Ricard Cervera" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Gerardo" "apellidos" => "Quintana-Lopez" "email" => array:1 [ 0 => "ge_quintana@yahoo.com" ] "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 3 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Gloria" "apellidos" => "Vásquez" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 2 => array:3 [ "nombre" => "Ricard" "apellidos" => "Cervera" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] ] "afiliaciones" => array:6 [ 0 => array:3 [ "entidad" => "Reumavance Group, Rheumatology Section, Department of Internal Medicine, Fundación Santa Fe de Bogotá University Hospital, Bogota, Colombia" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Department of Internal Medicine, School of Medicine, Universidad de Los Andes, Bogota, Colombia" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Cell Immunology and Immunogenetics Group (GICIG), School of Medicine, Universidad de Antioquia, Medellin, Colombia" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Rheumatology Group, School of Medicine, Universidad de Antioquia, Medellín, Colombia" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Un viejo conocido con nuevas tendencias: lupus eritematoso sistémico" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Once again, we face the challenges of the approach to systemic lupus erythematosus (SLE). That, that we could classify as an “old acquaintance” among autoimmunologists and other doctors interested in the care of this disease, continues to be a great challenge. In this supplement we present several topics where novelties in the diagnostic and therapeutic approach are highlighted. In this way, an outstanding group of experts from different parts of the world show us a state of the art, but above all, the innovations that have been taking place on the LES.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Initially, Quintana et al.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> present an update and protective measures for cardiovascular diseases and accelerated arteriosclerosis. The pathophysiological mechanisms, new associated molecules and some management approaches are presented in relation to this unfortunate outcome of SLE, present when adequate control of the disease is not achieved. On the other hand, in a fascinating review, Alarcón<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> illustrates the great heterogeneity of the disease and, at the same time, the challenges it poses for the proper preparation of clinical studies and our skills and limitations to understand the mechanisms of the disease; meanwhile, the first single-cell transcriptomics studies, their results and eventual applications in the clinical setting are presented.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The implications of the environment and how it affects the disease are exposed by Bastidas et al.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> who present an elegant work on the experiences published in Colombia and the region. Topics of ethnicity, gender, hormonal factors, among others, are presented and interesting epidemiological estimators related to each factor and involved in the development or relapse of SLE are presented. A state of the art on organ damage and how it affects the evolution, severity and prognosis of the disease; presenting the associated and protective factors and finally, the pharmacological strategies with the greatest impact on the delay and blocking of this powerful outcome of SLE, is presented by González et al.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">4</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Approaches to some more clinical aspects are presented by Rodríguez-Pintó et al.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">5</span></a> who present a remarkable review on the catastrophic antiphospholipid syndrome, including differential diagnoses and a discussion on the currently available therapeutic options and their possible complications. For the issue of pregnancy, Zamora-Medina et al.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">6</span></a> In a grandiose approach, present the guidelines for before, during and after the gestational process, as well as the guidelines for potential complications due to the presence of lupus nephritis, antiphospholipid and anti-Ro and anti-La antibodies and their different outcomes during pregnancy.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Another clinical topic of interest presented is bone involvement, both at the joint level and mineral density. Here, Frade-Sosa et al.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> present an update on joint manifestations in SLE where the relevance of new diagnostic strategies such as ultrasonography and resonance is highlighted and the need to propose new classifications is discussed. Also, that refractory forms of arthritis require the targeted use of immunosuppressive modifying medications and even biological therapies. On the other hand, there is a reduction in bone mineral density (osteoporosis and avascular necrosis) in patients with SLE, mainly related to the use of steroids. In this section, Fernández-Codina and Pope<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a> present a complete review of the subject, which includes risk factors, symptoms, diagnostic methods and possible pharmacological measures. It is worth highlighting the criteria for screening and surveillance, as well as the recommendations on treatment in the group of patients with SLE.</p><p id="par0050" class="elsevierStylePara elsevierViewall">The issue related to kidney involvement and its approach could not be left out. In this field Sánchez-Cubías et al.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a> present the importance of repeat biopsy in the outcomes of lupus nephritis. They highlight the importance of re-biopsy in patients with relapse or loss of effectiveness in treatment, the change from a non-proliferative lesion to a proliferative form, and changes in the therapeutic decisions of patients undergoing re-biopsy. Finally, Xipell et al.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> present an update on the importance of including and understanding tubulointerstitial injury and its repair mechanisms to improve the results of renal involvement in SLE, present innovations in renal pathology techniques and new biomarkers to recognize early lesion due to nephritis.</p><p id="par0055" class="elsevierStylePara elsevierViewall">Finally, Ríos-Garcés et al.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">11</span></a>. present a state of the art on target-to-treatment in SLE, highlighting the notable importance of having patients in remission or at least low disease activity. It talks about the different definitions of these terms, their important results over time and the heterogeneity of the scales, but always keeping in mind the objective of carrying out these outcomes to our patients.</p><p id="par0035" class="elsevierStylePara elsevierViewall">In conclusion, we cannot fail to thank the response we had from all the authors and guests to build this monograph, their delicate work and the great contributions they gave us. Undoubtedly, the Lupus monograph will be a bibliographic and reference source for many novice and expert colleagues and will give its contribution to narrow the scope of our main objective: to help patients who suffer from lupus.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "apendice" => array:1 [ 0 => array:1 [ "seccion" => array:1 [ 0 => array:4 [ "apendice" => "<p id="par0045" class="elsevierStylePara elsevierViewall">The Spanish translation of this article is available as supplementary material:<elsevierMultimedia ident="upi0005"></elsevierMultimedia></p>" "etiqueta" => "Appendix A" "titulo" => "Supplementary material" "identificador" => "sec0010" ] ] ] ] "multimedia" => array:1 [ 0 => array:5 [ "identificador" => "upi0005" "tipo" => "MULTIMEDIAECOMPONENTE" "mostrarFloat" => false "mostrarDisplay" => true "Ecomponente" => array:2 [ "fichero" => "mmc1.pdf" "ficheroTamanyo" => 36638 ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:11 [ 0 => array:3 [ "identificador" => "bib0055" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Quintana R, Pons-Estel GJ, Serrano R, Pons-Estel BA, Bruce IN. Accelerated atherosclerosis and cardiovascular disease in systemic lupus erythematosus. Rev Colomb Reumatol. 2021, https://doi.org/10.1016/j.rcreu.2021.03.002." ] ] ] 1 => array:3 [ "identificador" => "bib0060" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Alarcón Riquelme ME. The heterogeneity of systemic lupus erythematosus: looking for a molecular answer. Rev Colomb Reumatol. 2021, <a target="_blank" href="https://doi.org/10.1016/j.rcreu.2021.02.006">https://doi.org/10.1016/j.rcreu.2021.02.006</a>" ] ] ] 2 => array:3 [ "identificador" => "bib0065" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Bastidas Goyes AR, Mora C, Martin Arsanios D, Orduz K. Systemic lupus erythematosus, a disease conditioned by the environment. Rev Colomb Reumatol. 2021, <a target="_blank" href="https://doi.org/10.1016/j.rcreu.2021.03.003">https://doi.org/10.1016/j.rcreu.2021.03.003</a>" ] ] ] 3 => array:3 [ "identificador" => "bib0110" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "González LA, González LA, Santamaría-Alza Y, Alarcón GS. Organ damage in systemic lupus erythematosus. Rev Colomb Reumatol. 2021, <a target="_blank" href="https://doi.org/10.1016/j.rcreu.2021.01.008">https://doi.org/10.1016/j.rcreu.2021.01.008</a>" ] ] ] 4 => array:3 [ "identificador" => "bib0115" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Rodríguez-Pintó I, López-Benjume B, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome. Rev Colomb Reumatol. 2021. <a target="_blank" href="https://doi.org/10.1016/j.rcreu.2021.02.004">https://doi.org/10.1016/j.rcreu.2021.02.004</a>" ] ] ] 5 => array:3 [ "identificador" => "bib0120" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Zamora-Medina MC, Orozco-Guillén OA, Domínguez-Quintana M, Romero-Díaz J. Systemic lupus erythematosus and pregnancy: strategies before, during and after pregnancy to improve outcomes. Rev Colomb Reumatol. 2021. <a target="_blank" href="https://doi.org/10.1016/j.rcreu.2021.02.004">https://doi.org/10.1016/j.rcreu.2021.02.004</a>" ] ] ] 6 => array:3 [ "identificador" => "bib0085" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Frade-Sosa B, Sarmiento-Monroy JC, Salman-Monte TC, Corzo P, Gómez-Puerta JA. Diagnosis and treatment of articular manifestations in systemic lupus erythematosus. Rev Colomb Reumatol. 2021,https://doi.org/10.1016/j.rcreu.2021.05.003." ] ] ] 7 => array:3 [ "identificador" => "bib0090" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Fernández-Codina A, Pope JE. Osteoporosis and osteonecrosis in systemic lupus erythematosus. Rev Colomb Reumatol. 2021, <a target="_blank" href="https://doi.org/10.1016/j.rcreu.2021.02.005">https://doi.org/10.1016/j.rcreu.2021.02.005</a>" ] ] ] 8 => array:3 [ "identificador" => "bib0095" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Sánchez-Cubías SM, Guaracha-Basañez GA, Sandoval-Flores MG, Domínguez-Quintana M, Romero-Díaz J. Utility of repeat kidney biopsy in lupus nephritis. A systematic review. Rev Colomb Reumatol. 2021, <a target="_blank" href="https://doi.org/10.1016/j.rcreu.2021.02.003">https://doi.org/10.1016/j.rcreu.2021.02.003</a>" ] ] ] 9 => array:3 [ "identificador" => "bib0100" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Xipell M, Egan A, Lledó G, Villarreal JZ, Espinosa G, García-Herrera A, et al. Understanding tubulointerstitial injury and repair mechanisms paves the way for renal outcome improvement in lupus nephritis. Rev Colomb Reumatol. 2021, <a target="_blank" href="https://doi.org/10.1016/j.rcreu.2021.04.001">https://doi.org/10.1016/j.rcreu.2021.04.001</a>" ] ] ] 10 => array:3 [ "identificador" => "bib0105" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ríos-Garcés R, Espinosa G, van Vollenhoven R, Cervera R. Treat to target in systemic lupus erythematosus lupus. Rev Colomb Reumatol. 2021, <a target="_blank" href="https://doi.org/10.1016/j.rcreu.2021.05.002">https://doi.org/10.1016/j.rcreu.2021.05.002</a>" ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/01218123/00000028000000S1/v4_202404250855/S0121812321000657/v4_202404250855/en/main.assets" "Apartado" => array:4 [ "identificador" => "18309" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/01218123/00000028000000S1/v4_202404250855/S0121812321000657/v4_202404250855/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0121812321000657?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 3 | 0 | 3 |
| 2024 October | 15 | 0 | 15 |
| 2024 September | 28 | 4 | 32 |
| 2024 August | 19 | 4 | 23 |
| 2024 July | 9 | 0 | 9 |
| 2024 June | 8 | 5 | 13 |
| 2024 May | 11 | 1 | 12 |
| 2024 April | 11 | 3 | 14 |
| 2024 March | 14 | 5 | 19 |
| 2024 February | 12 | 2 | 14 |
| 2024 January | 12 | 3 | 15 |
| 2023 December | 6 | 11 | 17 |
| 2023 November | 12 | 4 | 16 |
| 2023 October | 16 | 1 | 17 |
| 2023 September | 27 | 1 | 28 |
| 2023 August | 5 | 1 | 6 |
| 2023 July | 11 | 5 | 16 |
| 2023 June | 9 | 2 | 11 |
| 2023 May | 15 | 1 | 16 |
| 2023 April | 5 | 4 | 9 |
| 2023 March | 2 | 1 | 3 |
| 2023 February | 0 | 3 | 3 |
| 2023 January | 4 | 2 | 6 |
| 2022 December | 10 | 2 | 12 |
| 2022 November | 16 | 7 | 23 |
| 2022 October | 10 | 2 | 12 |
| 2022 September | 10 | 9 | 19 |
| 2022 August | 9 | 6 | 15 |
| 2022 July | 13 | 6 | 19 |
| 2022 June | 6 | 6 | 12 |
| 2022 May | 9 | 7 | 16 |
| 2022 April | 8 | 6 | 14 |
| 2022 March | 10 | 5 | 15 |
| 2021 July | 7 | 2 | 9 |
| 2021 June | 4 | 10 | 14 |
| 2021 May | 0 | 2 | 2 |
Show all
